Phase 2 Readout
PRAX: Phase 2 Readout: relutrigine
June 30, 2026 · relutrigine. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- June 30, 2026
- Company
- Praxis Precision Medicines, Inc. (PRAX)
- Drug
- relutrigine
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: relutrigine
- Drug
- relutrigine
- Indication
- SCN2A and SCN8A developmental and epileptic encephalopathies